The 5 Most Interesting Analyst Questions From Cencora's Q3 Earnings Call [Yahoo! Finance]
Cencora, Inc. (COR)
Last cencora, inc. earnings: 4/30 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.coresite.com/investor-overview
Company Research
Source: Yahoo! Finance
Management pointed to strong growth in its U.S. Healthcare Solutions segment and the contribution of specialty pharmaceuticals as key drivers. CEO Robert Mauch emphasized that investments in areas like specialty distribution and recent acquisitions, such as Retina Consultants of America, enhanced the company's value to both pharmaceutical manufacturers and healthcare providers. The segment's operating income growth, driven by volume increases and higher-margin specialty products, was a highlight for the quarter. Is now the time to buy COR? Find out in our full research report (it's free for active Edge members). Cencora (COR) Q3 CY2025 Highlights: Revenue: $83.73 billion vs analyst estimates of $83.28 billion (5.9% year-on-year growth, 0.5% beat) Adjusted EPS: $3.84 vs analyst estimates of $3.79 (1.4% beat) Adjusted EBITDA: $1.18 billion vs analyst estimates of $1.14 billion (1.4% margin, 3.4% beat) Adjusted EPS guidance for the upcoming financial year 2026 is $17.60 at th
Show less
Read more
Impact Snapshot
Event Time:
COR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COR alerts
High impacting Cencora, Inc. news events
Weekly update
A roundup of the hottest topics
COR
News
- Why Cencora (COR) Shares Are Trading Lower Today [Yahoo! Finance]Yahoo! Finance
- Cencora (COR) Upgraded to Buy: Here's Why [Yahoo! Finance]Yahoo! Finance
- Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- How Investors Are Reacting To Cencora (COR) Expanding Global Reach With Alliance Healthcare Acquisition [Yahoo! Finance]Yahoo! Finance
- Cencora (NYSE:COR) had its price target raised by analysts at JPMorgan Chase & Co. from $344.00 to $417.00. They now have an "overweight" rating on the stock.MarketBeat
COR
Earnings
- 11/5/25 - Beat
COR
Sec Filings
- 11/25/25 - Form 10-K
- 11/24/25 - Form 4
- 11/24/25 - Form 4
- COR's page on the SEC website